Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HR+/HER2- metastatic breast cancer: a retrospective chart review in community oncology practices in the US. [electronic resource]
Producer: 20151201Description: 1095-103 p. digitalISSN:- 1473-4877
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Everolimus -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Postmenopause
- Proportional Hazards Models
- Receptor, ErbB-2 -- metabolism
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.